| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5583964 | Seminars in Arthritis and Rheumatism | 2017 | 7 Pages |
Abstract
Our small series suggests that tocilizumab may be a promising alternative for Takayasu arteritis treatment. Long-term controlled studies are warranted to provide better evidence for tocilizumab treatment in childhood Takayasu arteritis.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Ezgi Deniz MD, Hafize Emine MD, Tuncay MD, Fatih MD, Yelda MD, Seza MD,